Does there need to be a change of leadership at JNJ

disclosure.

ok.

i will never take another tylenol as long as i live

yeah, that makes sense.

thanks anyway.

I'm not sure whether you mean marketing or safety. As the marketing authorisation holders for a wide range of therapies for different companies they used to have global reporting responsibilities. The measure of which is correlated to industry wide compliance with respect reporting. Ideally it would be 100%. Though this doesn't always happen because of a wide range of mistakes. If a company chronically mis-marketed aspects of safety the repercussions could be costly in as much as the FDA, EMEA etc would want to know about it.

"Different times." There are many reasons for communication failures and the responsibility for it is not normally down to just one person. These would be similar to that in many offices that deal with high volumes of requests. If one person gets the blame I would guess it will normally be a boss covering a more general problem. Though it could be a wide range of issues.

Note above. I have spelt "Tyelnol" wrong. It should be "Tylenol". It's small clerical error that would be picked up in a safety department. Poor spelling is slack, especially with regards pharmacy. Though poor pharmacy would be what lead to a wider investigation, I would guess. If a prescriber, pharmacist etc, spelt the name of product wrong they should be reported.

As regards pharmacy there are two types of production process. Batch and continuous. I would Google these words and investigate there relevance with respect Tylenol production. If a batch process was used it is likely that only that batch would be faulty in which case it would investigated.

I guess it's possible. Though the very fact that tasks are routine would mean it is unlikely there will be any huge mistakes. It's a competitive industry so people who are uninterested are encouraged to move on to another job function. Apparently JNJ pay above that market rate though I honestly couldn't tell you whether it is true or not. I would doubt that people are deliberately lazy. I guess someone may be employed out of position and this could lead to difficulties. Either that or some kind of personal dispute which could happen in any workplace.

As far as I understand drug safety and pharmacovigilance with respect clinical trials and postmarketing study has only been an active part of the industry since 1998 or so and has been slowly evolving since then. Most companies have had "difficulties" of some kind I would expect. Though it is how they deal with them that sets them apart.

What is the "CHPV" you mentioned? It's not a term I heard before.

I live in the UK. You're right. I've not ever been on the government payroll. In the UK, government workers are fiercely defensive of their unions and pensions etc. If you're a private sector worker like I have been, it feels like you just have to roll with the punches and take what's coming. There's not much else to it as far as I have been informed.

I guess one thing I could do if I was rich and had shares would be to put pressure on the public sector who most definitely purchase from the private. Whether it be physical product or a skilled service. I do have shares but I have little ability to tip the scales financially as an individual. I would guess there are not many people in the same position in the UK.

When I was employed at JNJ I worked hard most of the time. It strikes me that others can often find an excuse for calling someone else lazy, especially if they have a problem/s of their own. That's just my point of view.

The device looks like it is something for someone who needs it to be clean. Is it for intravenous anti-biotics? Not a nice place to have to think about having an infection.

Your local safety officer will probably be the first point of contact for health care professionals in your area. This will probably be for McNeil rather than JNJ as a whole. It's possible to contact them yourself and ask them about the safety of their product although they will probably just quote you the safety documentation that comes on the packet insert as this is all they are legally obliged to do.

I would guess the case you are talking about specifically has already been reported. If not, perhaps try here.

http://www.fda.gov/MedicalDevices/Safety/default.htm